Search results
Novo Nordisk’s ocedurenone Phase III flop costs company $816m
Clinical Trials Arena· 7 days agoThe trial was estimated to enrol approximately 600 patients from 150 sites in the US, Europe, and...
Samsung Bioepis’ PYZCHIVA gains FDA approval as Stelara biosimilar
Pharmaceutical Technology· 2 days agoFurther clinical evidence from a Phase III trial involving patients with moderate to severe plaque...
UPSC Key | Buffer stocks, JP Morgan Index, Hijab ban and more
Indian Express· 6 days agoExclusive for Subscribers Daily: How are NEET/NET fiasco and Buffer stocks relevant to the UPSC...
Alumis raises $250m in IPO as biotech stock stirs
Pharmaceutical Technology· 6 days agoThe offering is expected to close on 1 July. Earlier this month, the US-based biotech said that it planned to use part of the IPO proceeds to advance its...
FDA go-ahead for Verona Ohtuvayre transforms US COPD exacerbator market
Clinical Trials Arena· 7 days agoThe asset is tailored towards patients with moderate to severe exacerbations with chronic...
TauRx seeks UK MHRA approval for Alzheimer’s treatment
Pharmaceutical Technology· 3 days agoThe UK regulator had previously designated the innovative licensing and access pathway...approving...
EMA approves Sanofi’s Dupixent for COPD treatment in adults
Pharmaceutical Technology· 20 hours agoDupixent's approval is supported by the findings from the Phase III BOREAS and NOTUS studies. These...
UPSC Key | Semiconductor, Hooch tragedy, NHRC and more
Indian Express· 4 days agoThe Indian Express UPSC Essentials brings to you the June edition of its monthly magazine. What’s...
Verona scores FDA approval for Ohtuvayre as COPD maintenance therapy
Pharmaceutical Technology· 7 days agoThe Ohtuvayre approval was based on the positive results from Phase III ENHANCE-1 and ENHANCE-2...
EAN 2024: Benefits of early migraine treatment clear but implementation remains challenging
Clinical Trials Arena· 15 hours agoA further key challenge highlighted during the symposium is that due to the variability of migraine...